$QSI News

Quantum-Si incorporated (QSI) Shareholder/Analyst Call Prepared Remarks Transcript

Quantum-Si (QSI) Reports Q1 2026 Revenue Miss but Beats EPS Amid Proteus Launch Preparations

Quantum-Si Affirms FY2026 Sales Guidance of $1.000M vs $1.047M Est

Quantum-Si Q1 EPS $(0.10) Beats $(0.11) Estimate, Sales $258.000K Miss $298.667K Estimate

Canaccord Genuity Maintains Hold on Quantum-Si, Lowers Price Target to $1

Quantum-Si incorporated (QSI) Q4 2025 Earnings Call Transcript

Quantum-Si (NASDAQ:QSI) Reports Q4 2025 Revenue Miss, Guides for Strategic Transition Year

Quantum-Si Shares Slip After Q4 Revenue Miss

Quantum-Si Sees FY2026 Sales $1.000M vs $7.148M Est

Quantum-Si Sees FY2026 Sales $1.000M vs $7.148M Est

Quantum-Si Q4 EPS $(0.08) Beats $(0.12) Estimate, Sales $451.000K Miss $762.000K Estimate

Earnings Breakdown: Quantum-Si Q4

Examining the Future: Quantum-Si's Earnings Outlook

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Quantum-Si to Report Fourth Quarter and Full Year 2025 Financial Results on March 3, 2026

Quantum-Si Announces the Release of Two New Manuscripts Demonstrating the Value of Single-Molecule Protein Sequencing in Clinical Proteomics and Pathogen & Toxin Detection

Quantum-Si Releases Two Manuscripts On Single-Molecule Protein Sequencing For Hemoglobin Variant Identification And Pathogen And Toxin Detection

Quantum-Si (NASDAQ:QSI) shareholders have endured a 89% loss from investing in the stock five years ago

Quantum-Si Announces Launch of New Version 3 Library Preparation Kit and a Suite of Data Analysis Tool Enhancements

Canaccord Genuity Maintains Hold on Quantum-Si, Lowers Price Target to $1.5